The world's leading automated proofreading software

Calculate Your ROI with TVT | Help Centre | e-Learning Login

Book a demo

Proofreading in the European Pharma Industry: Challenges and Misconceptions

Published By:

Dr. Jutta Hohenhoerst

2 minutes read

Original Broadcast Date: March 11th, 2020
Length: 60 minutes

Overview:

No other industry in the world is more highly regulated than Pharma with and with good reason. For the people responsible for getting pharmaceuticals on the shelves it means ensuring that all information produced in the packaging process – inserts, labels, cartons, etc. must be 100% error free.

How can you achieve this level of accuracy?

Eliminate your risk of misprints and perfect your pharma proofreading process by watching this webinar and using TVT.

The Presenters

About Kirsten Ott

Kirsten Ott, Marketing and Artwork Manager, has been working at CLS Labeling Support eK since 2016. The CLS Labeling Support Team is dedicated to support the Pharma Industry in Germany and throughout Europe from manuscript creation to the final label. Ott is confronted on a daily basis with Pharma challenges around labeling and proofreading.

About Schlafender Hase

Since Schlafender Hase® introduced TVT®, the Text Verification Tool® this software has taken the lead in providing intelligent, automated text and graphic proofreading solutions for the most regulated industries. Schlafender Hase’s client roster includes the world’s leading pharmaceutical and medical device companies. The company is proud to be known for product quality, service excellence and customer success. Founded in 2001, the company is headquartered in Frankfurt, Germany with a North American division in Cambridge, Massachusetts.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Share this article

Dr. Jutta Hohenhoerst

Regional Sales Director, Schlafender Hase

Dr. Jutta Hohenhörst has more than 22 years experience in the pharmaceutical business.

Follow Us

Categories

Categories

Subscribe to our blog

Original Broadcast Date: March 11th, 2020
Length: 60 minutes

Overview:

No other industry in the world is more highly regulated than Pharma with and with good reason. For the people responsible for getting pharmaceuticals on the shelves it means ensuring that all information produced in the packaging process – inserts, labels, cartons, etc. must be 100% error free.

How can you achieve this level of accuracy?

Eliminate your risk of misprints and perfect your pharma proofreading process by watching this webinar and using TVT.

The Presenters

About Kirsten Ott

Kirsten Ott, Marketing and Artwork Manager, has been working at CLS Labeling Support eK since 2016. The CLS Labeling Support Team is dedicated to support the Pharma Industry in Germany and throughout Europe from manuscript creation to the final label. Ott is confronted on a daily basis with Pharma challenges around labeling and proofreading.

About Schlafender Hase

Since Schlafender Hase® introduced TVT®, the Text Verification Tool® this software has taken the lead in providing intelligent, automated text and graphic proofreading solutions for the most regulated industries. Schlafender Hase’s client roster includes the world’s leading pharmaceutical and medical device companies. The company is proud to be known for product quality, service excellence and customer success. Founded in 2001, the company is headquartered in Frankfurt, Germany with a North American division in Cambridge, Massachusetts.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Subscribe to our blog

Follow Us

Categories

Past Webinars

November 19, 2024

Schlafender Hase Team

The Game-Changing Features of TVT 12: A New Era in Compliance and Efficiency

TVT 12 is here! This annual update is packed exclusively with new features and improvements from customer requests that support key industry initiatives, boost efficiency, and add even more speed and detail to your document reviews.

< 1 minute read

The Game-Changing Features of TVT 12: A New Era in Compliance and Efficiency

TVT 12 is here! This annual update is packed exclusively with new features and improvements from customer requests that support key industry initiatives, boost efficiency, and add even more speed and detail to your document reviews.

October 30, 2024

Schlafender Hase Team

How are increased compliance requirements impacting medical devices?

How are increased compliance requirements impacting medical devices? Discover the Future of Medical Device Regulation. We will dive into the rapid growth of the medical device sector, driven by cutting-edge technologies and rising regulatory requirements.

2 minutes read

How are increased compliance requirements impacting medical devices?

How are increased compliance requirements impacting medical devices? Discover the Future of Medical Device Regulation. We will dive into the rapid growth of the medical device sector, driven by cutting-edge technologies and rising regulatory requirements.

October 9, 2024

Schlafender Hase Team

Learning the New Language of the EMA & The FDA: FHIR

Watch our interactive discussion session focusing on the evolution and outlook of Fast Healthcare Interoperability Resources (FHIR). FHIR represents a significant step in how we manage and exchange information and is rapidly gaining acceptance. In this session, industry experts will provide an introduction to the FHIR initiative, explore some current applications as well as the impacts, benefits and prospective timelines.

2 minutes read

Learning the New Language of the EMA & The FDA: FHIR

Watch our interactive discussion session focusing on the evolution and outlook of Fast Healthcare Interoperability Resources (FHIR). FHIR represents a significant step in how we manage and exchange information and is rapidly gaining acceptance. In this session, industry experts will provide an introduction to the FHIR initiative, explore some current applications as well as the impacts, benefits and prospective timelines.